France Veterinary Healthcare Market Insights Forecasts to 2033

• The Market is Growing at a CAGR of 3.95% from 2023 to 2033
• The France Veterinary Healthcare Market Size is Expected to Hold a Significant Share by 2033

The France Veterinary Healthcare Market is Anticipated to Hold a Significant Share by 2033, growing at a CAGR of 3.95% from 2023 to 2033

Market Overview

The field of medicine that deals with the illness, injury, and diagnosis and treatment of animal species is known as veterinary healthcare. The field of veterinary medicine is broad, encompassing all domestic and wild animal species as well as a vast spectrum of ailments that can impact various species. Providing veterinary treatment is a crucial part of caring for animals. To maintain the health of animals, it offers veterinary medical and surgical procedures such as immunizations and wound care. It also includes preventative care, which includes dental treatment, nutritional counseling, and parasite control. Zoo and lab animal care may be included in veterinary healthcare, which may concentrate on the care of working, companion, agricultural, or wild animals.     

Report Coverage

This research report categorizes the market for the France veterinary healthcare market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France veterinary healthcare market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France veterinary healthcare market.

Driving Factors

According to the World Organization for Animal Health (WOAH), there has been another outbreak of Aujeszky's illness in France. On 28 September 2023, seven positive cases were found on a 200-animal pig farm in Entrepierres, Alpes-de-Haute-Provence, which marked the beginning of the outbreak. Such incidents emphasize the critical requirement for effective animal health care and disease prevention strategies, and they also raise the requirement for veterinary healthcare in France. Throughout the forecast period, increasing ownership of pets and consumer worries over the welfare of animals and nutrition security are anticipated to drive market expansion.

Restraining Factors

The use of counterfeit drugs, a lack of funding and facilities, and the rising cost of veterinary care, however, are expected to obstruct the market's growth.

Market Segmentation

The France veterinary healthcare market share is classified into product and animal type.

• The therapeutics segment is expected to hold the largest market share through the forecast period.   

The France veterinary healthcare market is segmented by product into therapeutics and diagnostics. Among these, the therapeutics segment is expected to hold the largest market share through the forecast period. Animal health issues are the main reason for using therapeutics. This covers prescription drugs and other medical care for injuries, chronic illnesses, infectious disorders, and other conditions. Veterinary medicines have a crucial role in reducing pain and enhancing the standard of life for sick animals.

• The ruminants segment is expected to dominate the France veterinary healthcare market during the forecast period.       

Based on the animal type, the France veterinary healthcare market is divided into dogs and cats, horses, ruminants, swine, poultry, and others. Among these, the ruminants segment is expected to dominate the France veterinary healthcare market during the forecast period. Cattle, sheep, and goats belong to those animals classified as ruminants. Veterinary medical treatment of ruminants includes managing the health of the livestock, providing reproductive health services, evaluating diet, and treating illnesses and ailments which impact these animals which are frequently bred for meat, milk, and wool.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France veterinary healthcare market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boehringer Ingelheim International GmbH
• Ceva Animal Health, Inc.
• Elanco
• IDEXX Laboratories
• Merck & Co. Inc.
• Vetoquinol
• Zoetis Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In April 2024, as crucial studies in important research areas proceeded as expected in 2023, Boehringer Ingelheim announced a significant advancement of its workflow. Investments in research and development (R&D) rose by 14.2% to EUR 5.8 billion.

Market Segment

This study forecasts revenue at France, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the France Veterinary Healthcare Market based on the below-mentioned segments:

France Veterinary Healthcare Market, By Product

• Therapeutics
• Diagnostics

France Veterinary Healthcare Market, By Animal Type

• Dogs and Cats
• Horses
• Ruminants
• Swine
• Poultry
• Others